C12Y304/21004

PROTEASE COMPOSITIONS FOR USE IN MODIFYING SEMEN
20170354594 · 2017-12-14 ·

Provided herein are edible compositions for reducing semen viscosity and/or enhancing semen flavor, and methods of using and preparing such compositions.

PROCESS FOR PRODUCING RECOMBINANT TRYPSIN
20170335308 · 2017-11-23 · ·

A process for producing recombinant trypsin from prokaryote host cells in high yield and high specific activity is described. In particular, a process for producing recombinant trypsin from E. coli is described.

Decellularization of Plant Cell Culture Materials for Tissue Engineering and Drug Delivery
20220054710 · 2022-02-24 ·

Provided herein are enzymatically decellularized cells, and methods of producing said cells, that can be used in a scaffold. The scaffolds featured herein are biocompatible and can comprise decellularized cells that have been modified to express a bioactive agent or molecule.

Anti-VEGF protein compositions and methods for producing the same

The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.

IMMUNO-MALDI TO MEASURE AKT1 AND AKT2 PHOSPHORYLATION

This application relates to methods of quantifying AKT1 and AKT2 and determining AKT1 and AKT2 phosphorylation status. The disclosed methods allow for selection of cancer therapy.

HYDROLYSED PHOSPHOLIPID COMPOSITION AND METHOD OF MAKING THE SAME

There is a method of producing a hydrolysed egg yolk plasma product from egg yolk elements. The egg yolk elements include phospholipids and proteins. The method comprises introducing a hydrolysing agent into the egg yolk elements to hydrolyse at least a portion of the proteins in the egg yolk elements to form the hydrolysed egg yolk plasma product. There also is a composition formed using the method above. There is also an egg yolk composition formed from egg yolk, comprising at least 15% phospholipids solids by dry mass, at least 20% protein by dry mass, the protein being at least partially hydrolysed into peptides and at least 40% lipids other than phospholipids by dry mass.

PREVENTION, TREATMENT AND DIAGNOSIS OF P.GINGIVALIS INFECTION

The invention relates to generation and use of cellular and humoral responses for the prevention and treatment of P. gingivalis related conditions and diseases.

CHEMICALLY STABLE HOLLOW SPERICAL COF AND SYNTHESIS THEREOF

This present invention relates to a chemically stable hollow spherical covalent organic framework having mesoporous walls with high surface area and a process for synthesis thereof. Further the immobilization and adsorption ability of the said COF's is disclosed in the present invention.

SOLUBILIZATION OF MSW WITH BLEND ENZYMES

The present invention relates to a method for solubilisation or hydrolysis of Municipal Solid Waste (MSW) with an enzyme blend and an enzyme composition for solubilization of Municipal Solid Waste (MSW), the enzyme composition comprising a cellulolytic background composition and a protease, lipase and/or beta-glucanase.

SOLUBILIZATION OF MSW WITH BLEND ENZYMES

The present invention relates to a method for solubilisation or hydrolysis of Municipal Solid Waste (MSW) with an enzyme blend and an enzyme composition for solubilization of Municipal Solid Waste (MSW), the enzyme composition comprising a cellulolytic background composition and a protease, lipase and/or beta-glucanase.